Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Nature Reviews Drug Discovery 22, 521-522 (2023)
The authors gratefully acknowledge the contributions of Colin Pillai and David Mukanga (CTC), Nicola Mulder (H3Africa), Bernhards Ogutu (PANTHER), Collet Dandara and Collen Masimirembwa (African Pharmacogenomics Consortium), who provided valuable feedback during the preparation of this article. K.C. is the Neville Isdell Chair in African-centric Drug Discovery and Development and thanks Neville Isdell for generously funding the Chair.
Sirugo, G., Williams, S. M. & Tishkoff, S. A. The missing diversity in human genetic studies. Cell 177, 26–31 (2019).
Dandara, C. et al. African Pharmacogenomics Consortium: Consolidating pharmacogenomics knowledge, capacity development and translation in Africa. AAS Open Res. 2, 19 (2019).
Rajman, I., Knapp, L., Morgan, T. & Masimirembwa, C. African genetic diversity: implications for cytochrome P450-mediated drug metabolism and drug development. EBioMedicine 17, 67–74 (2017).
Choudhury, A. et al. High-depth African genomes inform human migration and health. Nature 586, 741–748 (2020).
Winks, S., Woodland, J. G., Pillai, G. ‘Colin’ & Chibale, K. Fostering drug discovery and development in Africa. Nat. Med. 28, 1523–1526 (2022).
The authors declare no competing interests.